In this respect, combining DC vaccination with treatment regimens other than chemotherapy, such as immune checkpoint inhibitors and inhibitors of the RAS/RAF/MEK/ERK pathway, may be worthy of further consideration to circumvent the complex tumor escape mechanisms and thus to achieve better clinical responses. Here, MAP2K7 is linked to neoplasm.